Introduction
============

Lung cancer consists of non-small cell lung cancer and small cell lung cancer. Non-small cell lung cancer accounts for about 85% in lung cancer ([@b1-ol-0-0-11631],[@b2-ol-0-0-11631]). The subtype of non-small cell lung cancer is generally lung adenocarcinoma, which accounts for about 40% in lung cancer ([@b3-ol-0-0-11631]). At present, the early diagnosis of patients with lung adenocarcinoma is still poor. Many patients are in the advanced stage or have metastasis when they are diagnosed, which makes the treatment of patients very difficult ([@b4-ol-0-0-11631],[@b5-ol-0-0-11631]). At present, small pulmonary nodules are treated by non-invasive methods such as chest computed tomography (CT) and MRI and invasive diagnostic methods such as biopsy and puncture ([@b6-ol-0-0-11631]). Chest CT is an optimal method to screen lung cancer, and has high resolution. The detection rate of lung ground glass nodules (GGN) is increasing with the application of chest CT ([@b7-ol-0-0-11631]).

GGN lesion can be divided into pure GGN (pGGN) lesion and mixed GGN (mGGN) lesion in CT imaging. It is shown that the malignant rate of GGN of early lung adenocarcinoma is high in thin slice CT. A total of 18% of pGGN and 63% of mGGN are malignant niduses ([@b8-ol-0-0-11631]). According to the classification criteria of International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS), lung adenocarcinoma can be divided into atypical adenomatous hyperplasia (AAH), adenocarcinoma *in situ* (AIS), microinvasive adenocarcinoma (MIA), and invasive adenocarcinoma (IAC) ([@b9-ol-0-0-11631],[@b10-ol-0-0-11631]). AAH and AIS are considered as pre-invasive lung adenocarcinoma, and MIA and IAC as invasive lung adenocarcinoma. However, there are pGGN or mGGN in AAH, AIS, MIA, and IAC and there are different solid components in CT imaging ([@b11-ol-0-0-11631],[@b12-ol-0-0-11631]). There are significant differences between the operation of pre-invasive lung adenocarcinoma and the operation of invasive lung adenocarcinoma. Also, the lymph node structure of patients with pre-invasive lung adenocarcinoma or invasive lung adenocarcinoma is different ([@b13-ol-0-0-11631],[@b14-ol-0-0-11631]). Therefore, it is crucial to discriminate invasive lesions and invasive lung adenocarcinoma accurately, especially in terms of operation plan, prognosis assessment, and doctor-patient communication.

With the development of CT technology, multi-detector CT (MDCT) is used to screen tumors, because its time resolution is good, and it can process data in a same direction and has various image processing functions ([@b15-ol-0-0-11631]). In the present study, MDCT was used to examine GGN patients. The imaging features of MDCT and its predictive value for pre-invasive lung adenocarcinoma and invasive lung adenocarcinoma were investigated.

Patients and methods
====================

### General data

The data of 168 patients with pulmonary GGN were analyzed. These patients were diagnosed in Shengli Oilfield Central Hospital (Dongying, China) from January 2013 to June 2015. According to the classification criteria of IASLC/ATS/ERS ([@b16-ol-0-0-11631]), there were 11 patients with AAH, 59 patients with AIS, 29 patients with MIA, and 69 patients with IAC. Patients with MIA and IAC were included in group A (invasive lung adenocarcinoma, n=98), and patients with AAH and AIS were included in group B (pre-invasive lung adenocarcinoma, n=70). There were 38 patients with pGGN and 60 patients with mGGN in group A, including 41 males and 57 females, aged 36 to 81 years, with a mean age of (57.3±6.2). There were 51 patients with pGGN and 19 patients with mGGN in group B, including 32 males and 38 females, aged 35 to 79 years, with a mean age of (57.9±6.1).

This study was approved by the Ethics Committee of Shengli Oilfield Central Hospital. Signed informed consent was obtained from the patients or their guardians.

### Inclusion and exclusion criteria

Inclusion criteria: Patients with lung adenocarcinoma according to postoperative histopathological diagnosis ([@b17-ol-0-0-11631]); with complete medical record; without primary tumors and patients with blood sugar levels at normal levels. Exclusion criteria: Patients with history of iodine allergy and other drug allergies; with history of thoracic surgery; with other tumors; complicated with severe liver dysfunction and kidney dysfunction; with acute pulmonary infection, connective tissue diseases, infectious diseases, metabolic diseases, hematopoietic dysfunction and patients with mental illness or a family history of mental illness, pregnant or lactating women.

### MDCT examination

Patients were scanned by a SOMATOM Definition AS+ 64-row 128-slice spiral CT scanner (Siemens Healthcare GmbH). The patients took a supine position, with their heads close to the scanner, then they took a deep breath and held the breath. Scope: Between the sternoclavicular joint and the base of lungs, including the chest wall and armpits on both sides. The sternoclavicular joint was used as a baseline. Scanning parameters: Tube current 170 mAs; tube voltage 120 kV; visual field 350 mm; layer thickness 5 mm; and reconstruction thickness 2 mm. Subsequently, an enhanced examination was performed. The contrast agent, iopamidol with a concentration of 1.5 ml/kg, was injected into the elbow vein of the patients by a high pressure injector at a rate of 2.5 ml/sec, and the dosage was between 80 and 100 ml (Shanghai Bracco Sine Pharmaceutical Corp. Ltd.; H20053388). After this step was finished, the patients took a deep breath and held the breath, then their lungs were scanned. The window level of mediastinal imaging was 220 HU, the window width was 40 HU. The width of the lung window was 1,600 HU, the window level was −600 HU. After the patients were scanned, the data were input into Extended Brilliance^TM^ workstation and the imaging was rebuilt.

### Imaging analysis

Data were observed, including type of nidus (single and multiple), site of nidus (left, right), size of nidus (the length, diameter, axis of nidus and the length of solid component), size of solid component (the diameter of solid component), nature of nidus (pGGN, mGGN), pleura, burr, lobe, periphery, vacuole, and similar round. CT imaging was analyzed by two radiologists.

### Statistical analysis

Statistical analysis was performed by SPSS 22.0 (IBM Corp). The count data were expressed as \[n (%)\]. Chi-square test was used to compare the count data between groups. The measurement data were expressed as mean value ± standard deviation (mean ± SD). Independent sample t-test was used to compare the measurement data between groups. ROC curves of the size of nidus and size of solid component were drawn. Logistic multivariate regression analysis was used to analyze the risk factors that affect invasive lung adenocarcinoma. P\<0.05 indicates that the difference is statistically significant.

Results
=======

### General data of the patients in two groups

There was no significant difference in general data of the patients in groups A and B, including sex, age, body mass index, smoking history, respiratory symptoms, family history of cancers, carcinoembryonic antigen (CEA), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (P\>0.05) ([Table I](#tI-ol-0-0-11631){ref-type="table"}).

### Imaging features of MDCT of the patients in two groups

Size of nidus of patients in group B was smaller, many patients in group B had pGGN. Many patients in group A had mGGN. There were no or only a few solid components in mGGN in the plain scan. Solid components could be seen after CT was enhanced. In the imaging of MDCT of patients in group A and B, there was no significant difference in the type of nidus, site of nidus, pleural indentation, clear periphery, vacuole, and the ratio of similar round (P\>0.05). There were significant differences in the nature of nidus, burr, and lobes of patients in group A and B (P\<0.05). Sizes of nidus and solid components of patients in group A were significantly bigger than those of patients in group B (P\<0.05) ([Table II](#tII-ol-0-0-11631){ref-type="table"}).

### Diagnostic value of the size of nidus and the size of solid component for invasive lung adenocarcinoma

ROC curves of the size of nidus and the size of solid component in invasive lung adenocarcinoma were drawn. AUC of the size of nidus in the treatment of invasive lung adenocarcinoma was 0.891 (95% CI: 0.843--0.939), and sensitivity was 83.67%; specificity was 81.43%, and optimal cut-off value was 9.8 mm. AUC of the size of solid component in the treatment of invasive lung adenocarcinoma was 0.902 (95% CI: 0.854--0.949), and sensitivity was 88.78%; specificity was 80.00%, and the optimal cut-off value was 0.9 mm. ROC curve was plotted to investigate the diagnosis of the size of nidus combined with the size of the solid component for invasive lung adenocarcinoma. The combined AUC was 0.984 (95% CI: 0.969--0.999); sensitivity was 87.76%; and specificity was 100.00% ([Table III](#tIII-ol-0-0-11631){ref-type="table"} and [Fig. 1](#f1-ol-0-0-11631){ref-type="fig"}).

### Logistic multivariate regression analysis of risk factors of invasive lung adenocarcinoma

Logistic multivariate regression analysis was used to analyze different factors in pre-invasive lung adenocarcinoma and invasive lung adenocarcinoma. The result showed that the size of nidus (OR: 2.834, 95% CI: 1.577--5.092), the size of solid component (OR: 16.605, 95% CI: 4.037--20.611), the nature of nidus (OR: 2.998, 95% CI: 1.734--5.183), burr (OR: 12.033, 95% CI: 4.119--17.857), lobes (OR: 3.575, 95% CI: 1.836--6.085) were risk factors that affected invasive lung adenocarcinoma (P\<0.05) ([Tables IV](#tIV-ol-0-0-11631){ref-type="table"} and [V](#tV-ol-0-0-11631){ref-type="table"}).

Discussion
==========

At present, when CT is used to scan the lungs of patients, its imaging features are deficient for the diagnosis of GGN. AAH, AIS, MIA, and IAC can be manifested as pGGN or mGGN with a small amount of solid components in CT imaging. It is difficult to diagnose the nature of nidus accurately before operation only according to the imaging features of niduses in CT imaging ([@b18-ol-0-0-11631],[@b19-ol-0-0-11631]).

Histological biopsy is an important method to diagnose whether GGN that existed in the patients\' body for a long time is an IAC, but biopsy and histological examination may cause some trauma ([@b20-ol-0-0-11631]). The operation plans of pre-invasive lesion of lung adenocarcinoma and invasive lung adenocarcinoma are different. Diagnosing and timely treatment of pre-invasive lesion of lung adenocarcinoma and invasive lung adenocarcinoma can avoid unnecessary lymph node dissection and reduce the trauma of patients. Thus, the early cure rate can reach up to 100% ([@b21-ol-0-0-11631]). AAH, AIS, and MIA grow along respiratory bronchiolar wall and alveolar wall, and most of them are pGGN. If there are obvious local fibroblast proliferation, local accumulation of tumor cells or alveolar wall collapse, AAH, AIS, and MIA are often manifested as mGGN ([@b22-ol-0-0-11631],[@b23-ol-0-0-11631]). In this study, there were significant differences between the nature of nidus, burr, and lobes of pre-invasive lung adenocarcinoma and those of invasive lung adenocarcinoma. Pre-invasive lung adenocarcinoma manifests as pGGN, while invasive lung adenocarcinoma manifests as mGGN. The morphological features of non-lobulated periphery and non-burr periphery of some pre-invasive GGN lesions were similar to those in previous studies ([@b24-ol-0-0-11631],[@b25-ol-0-0-11631]). In pulmonary nodules, it is known that large nodules are more malignant than small nodules, and that the solid component of GGN represents a region of fibroblast proliferation or an invasive component of tumors ([@b26-ol-0-0-11631],[@b27-ol-0-0-11631]). In this study, the size of nidus and the size of solid component of patients in group A were significantly larger than those of patients in group B. This conclusion is similar to the conclusion in the study of Yoon *et al* ([@b28-ol-0-0-11631]). The sizes of nodules and solid components of MIA and IAC are larger than those of pre-invasive lung adenocarcinoma. ROC curves of nidus size and solid component size for the diagnosis of invasive lung adenocarcinoma were plotted, and it was found that the AUCs of the size of nidus, the size of solid component and the combination for the diagnosis of invasive lung adenocarcinoma were 0.891, 0.902 and 0.984, respectively. It suggested that the size of nidus and the size of solid component can be used as diagnostic parameters of invasive lung adenocarcinoma, and the combination of the two has better diagnostic efficiency. Logistic multivariate regression analysis was used to analyze risk factors of invasive lung adenocarcinoma. The result showed that the size of nidus, the size of solid component, the nature of nidus, burr, and lobes were risk factors of invasive lung adenocarcinoma. In the study of Lee *et al* ([@b29-ol-0-0-11631]), it was shown that the nidus with size of \<10 mm could distinguish pre-invasive lesions and invasive lesions; the smaller nidus size, the smaller solid proportion, the borderline without fissure and the borderline without spots were the significant distinguishing factors of the preinfiltrating lesion. In this study, it was found that the optimal cut-off values for lesion size and solid component size for invasive lung adenocarcinoma were 9.8 mm and 0.9 mm, respectively. Therefore, we consider that \<10 and 1 mm may be helpful in the diagnosis of invasive lung adenocarcinoma. Whether 10 and 1 mm can be used as alternatives need to be studied in the future. It was found in this study that nidus size combined with solid component size could improve the diagnostic efficacy of invasive lung adenocarcinoma, and confirmed that burr and lobes were risk factors for IAC, which were not reported before. Hu *et al* ([@b30-ol-0-0-11631]) used CT and positron emission tomography (PET) to show that the appearance of vacuole signs, pleural indentation signs, lobes, and burr-like appearance indicates that the lesion is more likely to be malignant than benign. For smaller GGN, the detection rate of PET-CT is lower, while for larger GGN the detection rate is higher. This study mainly used MDCT to distinguish between MIA, IAC and AAH, in AIS patients, and did not observe the CT signs of group A and B, which is one of the limitations of this study.

This study confirmed the diagnostic value of MDCT in the treatment of pre-invasive lung adenocarcinoma and invasive lung adenocarcinoma. However, the imaging features of MDCT of patients with AAH, AIS, MIA and IAC were not observed. There are some overlaps in the imaging features of MDCT of pre-invasive lung adenocarcinoma and invasive lung adenocarcinoma. Therefore, in clinical practice, clinical symptoms, signs, cytology, and histological examination should be jointly used to reduce misdiagnosis rate.

In conclusion, in GGN patients, nidus size and solid component size can be used as excellent diagnostic parameters for invasive lung adenocarcinoma, while nidus size (≥9.8 mm), solid component size (≥0.9 mm), mGGN nature of lesion, burr and lobes can distinguish invasive lung adenocarcinoma and preinvasive lesions.
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###### 

General data of the patients in groups A and B, n(%)/(mean ± SD).

  Categories                  Group A (n=98)   Group B (n=70)   t/χ^2^   P-value
  --------------------------- ---------------- ---------------- -------- ---------
  Sex                                                           0.250      0.617
    Male                      41 (41.84)       32 (45.71)                
    Female                    57 (58.16)       38 (54.29)                
  Age (years)                 57.3±6.2         57.9±6.1         0.534      0.623
  BMI (kg/m^2^)               22.26±3.59       22.89±3.47       1.137      0.257
  Smoking history                                               0.428      0.513
    Yes                       47 (47.96)       30 (42.86)                
    No                        51 (52.04)       40 (57.14)                
  Respiratory symptoms                                          0.744      0.388
    Yes                       19 (19.39)       10 (14.29)                
    No                        79 (80.61)       60 (85.71)                
  Family history of cancers                                     0.520      0.471
    Yes                       15 (15.31)       8 (11.43)                 
    No                        83 (84.69)       62 (88.57)                
  CEA (ng/ml)                 3.16±1.54        2.84±1.35        1.397      0.164
  AST (U/l)                   21.07±11.27      20.25±10.56      0.477      0.634
  ALT (U/l)                   27.63±9.48       28.41±9.24       0.531      0.596

BMI, body mass index; SD, standard deviation; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CEA, carcinoembryonic antigen.

###### 

Comparison of the imaging features of MDCT of the patients in groups A and B (mean ± SD).

  Categories                     Group A (n=98)   Group B (n=70)   t/χ^2^   P-value
  ------------------------------ ---------------- ---------------- -------- ---------
  Type of nidus                                                    0.049    0.826
    Single                       77 (78.57)       54 (77.14)                
    Multiple                     21 (21.43)       16 (22.86)                
  Site of nidus                                                    0.334    0.563
    Right                        53 (54.08)       41 (58.57)                
    Left                         45 (45.92)       29 (41.43)                
  Size of nidus (mm)             12.3±2.4         8.6±3.9          7.596    \<0.001
  Size of solid component (mm)   1.6±0.8          0.6±0.4          9.628    \<0.001
  Nature of nidus                                                  19.040   \<0.001
    pGGN                         38 (38.78)       51 (72.86)                
    mGGN                         60 (61.22)       19 (27.14)                
  Pleural indentation                                              3.323    0.068
    Yes                          10 (10.20)       2 (2.86)                  
    No                           88 (89.80)       68 (97.14)                
  Burr                                                             21.661   \<0.001
    Yes                          36 (36.73)       4 (5.71)                  
    No                           62 (63.27)       66 (94.29)                
  Lobes                                                            23.851   \<0.001
    Yes                          72 (73.47)       25 (35.71)                
    No                           26 (26.53)       45 (64.29)                
  Clear periphery                                                  2.661    0.103
    Yes                          81 (82.65)       64 (91.43)                
    No                           17 (17.35)       6 (8.57)                  
  Vacuole                                                          3.680    0.055
    Yes                          36 (36.73)       16 (22.86)                
    No                           62 (63.27)       54 (77.14)                
  Similar round                                                    1.721    0.190
    Yes                          65 (66.33)       53 (75.71)                
    No                           33 (33.67)       17 (24.29)                

MDCT, multi-detector CT; SD, standart deviation; mGGN, mixed ground glass nodules; pGGN, pure ground glass nodules.

###### 

The diagnostic value of the size of nidus and the size of solid component for invasive lung adenocarcinoma.

  Parameters                                AUC     95% CI         SE      Cut-off    Sensitivity (%)   Specificity (%)
  ----------------------------------------- ------- -------------- ------- ---------- ----------------- -----------------
  Size of nidus                             0.891   0.843--0.939   0.024   9.8 (mm)   83.67             81.43
  Size of solid component                   0.902   0.854--0.949   0.024   0.9 (mm)   88.78             80.00
  Size of nidus + size of solid component   0.984   0.969--0.999   0.001   0.9        87.76             100.00

AUC, area under the ROC curve; CI, confidence intervals; SE, standard error.

###### 

Logistic multivariate regression analysis and assignments.

  Factors                        Variate   Assignments
  ------------------------------ --------- -----------------
  Size of nidus (mm)             X1        ≥9.8=1, \<9.8=0
  Size of solid component (mm)   X2        ≥0.9=1, \<0.9=0
  Nature of nidus                X3        mGGN=1, pGGN=0
  Burr                           X4        Yes=1, No=0
  Lobes                          X5        Yes=1, No=0

mGGN, mixed ground glass nodules; pGGN, pure ground glass nodules.

###### 

Logistic multivariate regression analysis of risk factors of invasive lung adenocarcinoma.

  Factors                        β       SE      Wals     P-value   OR (95% CI)
  ------------------------------ ------- ------- -------- --------- ------------------------
  Size of nidus (mm)             1.042   0.299   12.128   \<0.001   2.834 (1.577--5.092)
  Size of solid component (mm)   4.036   1.347   8.975    0.003     16.605 (4.037--20.611)
  Nature of nidus                1.098   0.279   15.457   \<0.001   2.998 (1.734--5.183)
  Burr                           4.344   1.426   9.284    0.002     12.033 (4.119--17.857)
  Lobes                          2.808   0.816   11.831   0.001     3.575 (1.836--6.085)

SE, standard error; CI, confidence intervals.
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